COVID-19 information, guidance, and resources. Information about campus return and fall quarter planning. Additional health guidance available on the CDC's COVID-19 site. 

News

Content Tagged with: IBD

Drug found to correct gene defect that causes immune-driven gut leakiness

UC Riverside-led study is the first to show how tofacitinib rescues gut barrier function from overactive immune cells

By Iqbal Pittalwala | | Health

Understanding a gene’s role in inflammatory bowel disease

UC Riverside mouse study will identify mechanisms the gene PTPN2 uses to affect gut cells

By Iqbal Pittalwala | | Health

Drug decreases gut leakiness associated with ulcerative colitis

UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut

By Iqbal Pittalwala | | Health

Space travel can make the gut leaky

UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells

By Iqbal Pittalwala | | Health